CRIS Stock Analysis: Buy, Sell, or Hold?
CRIS - Curis Inc
$4.65
-0.10 (-2.11%)
▼
5d:
-12.1%
30d:
+990.01%
90d:
+650.12%
WAIT
LOW Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 04, 2026
20d
Get Alerted When CRIS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CRIS is down 12.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CRIS is down 12.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CRIS is currently trading at $4.65, which is considered extended relative to its 30-day fair value range of $-0.42 to $3.74.
Technical Outlook: Technically, CRIS is in a strong downtrend. The price is approaching resistance at $0.54. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CRIS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $280.00 (+5921.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CRIS is in a strong downtrend. The price is approaching resistance at $0.54. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CRIS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $280.00 (+5921.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$-0.42 -
$3.74
Company Quality Score
54/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.4%
All Signals
- BEARISH: Price significantly overextended (+24.3% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: Trading 5921.5% below Wall St target ($280.00)
- WARNING: Recommendation downgraded due to 24.3% overvaluation
Trading Range Analysis
30-Day Trading Range
$-0.42 -
$3.74
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.38
Resistance Level
$0.54
Current Trend
Strong Downtrend
Technical data as of
Jun 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.20
Wall Street Target
$280.00
(+5921.5%)
Revenue Growth (YoY)
-66.0%
Profit Margin
-299.7%
Share & Embed Analysis
Last updated: July 14, 2026 5:55 PM ET
Data refreshes hourly during market hours. Next update: 6:55 PM
Data refreshes hourly during market hours. Next update: 6:55 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRIS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$258 | 64 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 61 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 61 BUY |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 55 HOLD |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 59 HOLD |
